55.96
Nektar Therapeutics 주식(NKTR)의 최신 뉴스
Nektar Therapeutics (NASDAQ:NKTR) Shares Down 9.5%Time to Sell? - MarketBeat
Is it time to cut losses on Nektar TherapeuticsQuarterly Investment Review & Reliable Breakout Forecasts - newser.com
Why Nektar Therapeutics stock remains on buy lists2025 AllTime Highs & Verified Chart Pattern Trade Signals - newser.com
Can Nektar Therapeutics hit a new high this monthJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Is Nektar Therapeutics trending in predictive chart modelsJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - newser.com
Is Nektar Therapeutics stock a good choice for value investorsMarket Sentiment Report & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Nektar Therapeutics stockOil Prices & Verified Swing Trading Watchlist - newser.com
Pattern recognition hints at Nektar Therapeutics upsideGlobal Markets & Proven Capital Preservation Tips - newser.com
Published on: 2025-11-03 04:48:43 - newser.com
Why Nektar Therapeutics stock remains undervaluedJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
Will Nektar Therapeutics stock benefit from AI adoptionPortfolio Gains Summary & Community Consensus Picks - newser.com
Can Nektar Therapeutics (ITH0) stock sustain free cash flow2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
What margin trends mean for Nektar Therapeutics stockJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - newser.com
Using economic indicators to assess Nektar Therapeutics potential2025 Year in Review & Daily Momentum Trading Reports - newser.com
Moody Aldrich Partners LLC Invests $1.17 Million in Nektar Therapeutics $NKTR - MarketBeat
Will Nektar Therapeutics continue its uptrend2025 Analyst Calls & AI Driven Price Predictions - newser.com
Nektar Therapeutics (NKTR): Valuation Reset as REZOLVE-AD Phase 2b Data and Analyst Optimism Drive Investor Interest - simplywall.st
Is Nektar Therapeutics (ITH0) stock undervalued at current priceQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Nektar Therapeutics (NASDAQ:NKTR) Reaches New 1-Year HighShould You Buy? - MarketBeat
Is Nektar Therapeutics (ITH0) stock a top dividend aristocrat candidateJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
Nektar Therapeutics stock hits 52-week high at 65.97 USD By Investing.com - Investing.com Australia
Nektar Therapeutics (NKTR) Is Up 8.0% After Late-Breaking Phase 2b Rezpegaldesleukin Data Announcement - Sahm
Nektar Therapeutics stock hits 52-week high at 65.97 USD - Investing.com
Best data tools to analyze Nektar Therapeutics stock2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Nektar Therapeutics (NKTR): Taking a Fresh Look at Valuation After Recent Share Price Rebound - Yahoo Finance
Can volume confirm reversal in Nektar TherapeuticsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London - PR Newswire
Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Nektar Therapeutics $NKTR Holdings Trimmed by Deuterium Capital Management LLC - MarketBeat
자본화:
|
볼륨(24시간):